Overview

We Plan to Use Huato Zaizao Pills for Stroke Patients to Evaluate Their Efficacy and Safety and Divide 80 Subjects Into Two Groups at Random.

Status:
Recruiting

Trial end date:
2022-07-20

Target enrollment:
0

Participant gender:
All

Summary

This study is aiming to evaluate the efficacy and safety of Huatuo Zaizao pill in ischemic stroke patients who diagnosed as the phlegm and blood-stasis blocking collaterals syndrome in TCM. A total of 80 subjects will be randomly assigned to Huatuo Zaizao pill group or the control group.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Criteria

Inclusion Criteria:

- 1.Aged between 35 and 75 years old 2.With a disease course between 2 weeks- 24weeks
3.Meeting the diagnostic criteria of ischemic stroke 4.Meeting the diagnostic criteria
of phlegm and blood-stasis blocking collaterals pattern in T traditional Chinese
medicine 5.Signed and dated written informed consent.

Exclusion Criteria:

- 1.Unstable vital signs, or serious heart, liver, lung, kidney and other organ diseases
2.Exclude Transient Ischemic Attack(TIA) 3.Patients who are participating in clinical
trials of other drugs within the past 1 month 4.Pregnant or breastfeeding women